1. National Teacher Training Center For Health personnel. Clinical Ethics 1999;rev Ed. Seoul: Seoul National University Press.
2. Belmont Report. The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research 1979.
3. Kathleen CG, Duff W. The physician/investigato's obligation to patients participating in research: The case of placebo controlled trials. J Law Med Ethics 2005;33:575-585.
4. Korea Food&Drug Administration Public Notification No.2009-211. Korea Good Clinical Practice 2009;12. 22.
6. Korea Food&Drug Administration Public Notification No.2009-211. Korea Good Clinical Practice 2009;12. 22. Article 17.
7. Choi EK, Kim OJ. Ethical consideration in genomic cohort study. J Prev Med Public Health 2007;40:122-129. Korean.
8. Hofmann B. Broadening consent-and diluting ethics? J Med Ethics 2009;35:125-129.
9. Criteria for IRB approval of research 2007;45 C.F.R. Sect. 46. 111.
11. Civil Act of South Korea Ch. II. Article 4 (Majority).
12. Daugherty CK, Ratain MJ, Emanuel EJ, Farrell AT, Schilsky RL. Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials. J Clin Oncol 2008;26:1371-1378.
13. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med 1987;317:141-145.
14. National Bioethics Advisory Commission(NBAC). Ethical and Policy issues in Research involving Human Participants Volume I 2001.